Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

JAMA : the Journal of the American Medical Association
Gilda PiaggioCONSORT Group

Abstract

The CONSORT (Consolidated Standards of Reporting Trials) Statement, including a checklist and a flow diagram, was developed to help authors improve their reporting of randomized controlled trials. Its primary focus was on individually randomized trials with 2 parallel groups that assess the possible superiority of one treatment compared with another but is now being extended to other trial designs. Noninferiority and equivalence trials have methodological features that differ from superiority trials and present particular difficulties in design, conduct, analysis, and interpretation. Although the rationale for such trials occurs frequently, those designed and described specifically as noninferiority or equivalence trials appear less commonly in the medical literature. The quality of reporting of those that are published is often inadequate. In this article, we present an adapted CONSORT checklist for reporting noninferiority and equivalence trials and provide illustrative examples and explanations for those items amended from the original CONSORT checklist. The intent is to improve reporting of noninferiority and equivalence trials, enabling readers to assess the validity of their results and conclusions.

Citations

Apr 2, 2011·International Journal of Ayurveda Research·Saravu R NarahariKumbla R Suraj
Oct 17, 2013·American Journal of Respiratory and Critical Care Medicine·Pedro PóvoaJorge I F Salluh
Jan 29, 2014·BMC Pregnancy and Childbirth·Narayanan VallikkannuPeng Chiong Tan
Feb 7, 2014·The Journal of Primary Prevention·Matthew R SandersLouise J Keown
Jul 26, 2013·European Journal of Orthodontics·Nikolaos PandisTheodore Eliades
May 21, 2014·Cardiovascular Drugs and Therapy·A JalotaJ Halperin
Sep 16, 2014·Current Opinion in Pulmonary Medicine·Lesley Uttley, Paul Tappenden
Jan 5, 2011·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Chung-Wei Christine LinMaurits W van Tulder
Sep 18, 2014·The New England Journal of Medicine·Helen W BoucherMichael W Dunne
Nov 14, 2014·American Journal of Public Health·Gila NetaRoss C Brownson
Nov 26, 2013·Clinical Investigation·Meenakshi Devidas, James R Anderson
Aug 21, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Timothy John Collier
Apr 23, 2010·Obstetrics and Gynecology·Kenneth F SchulzUNKNOWN CONSORT Group
Apr 22, 2011·Obstetrics and Gynecology·Shawn E GurtcheffKirtly P Jones
May 3, 2013·Obstetrics and Gynecology·Sanne Adriana Lucia van LeijsenUNKNOWN Dutch Urogynecology Consortium
Jan 11, 2013·American Journal on Intellectual and Developmental Disabilities·Sara T Kover, Amy K Atwoo
Sep 22, 2006·BMC Medical Research Methodology·Jean-Jacques ParientiVéronique Massari
Jan 4, 2007·BMC Health Services Research·Franz PorzsoltVolker Amelung
Jul 31, 2007·BMC Medical Research Methodology·Norman A Desbiens
Nov 13, 2008·BMJ : British Medical Journal·Merrick ZwarensteinUNKNOWN Pragmatic Trials in Healthcare (Practihc) group
Jan 14, 2009·BMJ : British Medical Journal·Despina G Contopoulos-IoannidisJohn P A Ioannidis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.